Regulatory brokerage: Competitive advantage and regulation in the field of regenerative medicine (June 2019)
This article concerns the roles of entrepreneurial scientists in the co-production of life science research and regulation. Regulatory brokerage, defined as a mode of strategic planning and as the negotiation of regulation based on comparative advantage and competition, is expressed in scientific activities that take advantage of regulatory difference. This article is based on social science research in Japan, Thailand, India and the UK. Using five cases related to Japan’s international activities in the field of regenerative medicine, I argue that, driven by competitive advantage, regulatory brokerage at lower levels of managerial organization and governance is emulated at higher levels. In addition, as regulatory brokerage affects the creation of regulation at national, bilateral and global levels, new regulation may be based on competition in regulatory advantage rather than on ethical and scientific values. I argue that regulatory brokerage as the basis for regulatory reform bypasses issues that need to be decided by a broader public. More space is needed for international and political debate about the socio-political consequences of the global diversity of regulation in the field of the life sciences.
...MoreSimilar Citations
Article
Bronwyn Parry;
(January 2018)
The Social Life of “Scaffolds” Examining Human Rights in Regenerative Medicine
(/isis/citation/CBB220784562/)
Article
Alex Faulkner;
(2019)
Special Treatment? Flexibilities in the Politics of Regenerative Medicine’s Gatekeeping Regimes in the UK
(/isis/citation/CBB938616624/)
Article
Klaus Hoeyer;
(July 2015)
Regulatory Anatomy: How “Safety Logics” Structure European Transplant Medicine
(/isis/citation/CBB387324455/)
Article
Stephens, Neil;
Atkinson, Paul;
Glasner, Peter;
(December 2011)
Documenting the doable and doing the documented: Bridging strategies at the UK Stem Cell Bank
(/isis/citation/CBB128580755/)
Article
Dawn Goodwin;
(February 2018)
Cultures of caring: Healthcare ‘scandals’, inquiries, and the remaking of accountabilities
(/isis/citation/CBB580768540/)
Article
Eliane Portes Vargas;
Luciane da Costa Moás;
(2020)
Offer, consumption and freedom of information in the context of assisted reproduction in the digital age: Problematizing contractual guiding principles
(/isis/citation/CBB015757157/)
Article
Koichi Mikami;
(2015)
State-Supported Science and Imaginary Lock-in: The Case of Regenerative Medicine in Japan
(/isis/citation/CBB782339019/)
Article
John Gardner;
(September 2017)
Accelerating Innovation in the Creation of Biovalue: The Cell and Gene Therapy Catapult
(/isis/citation/CBB000462445/)
Article
Christine Hauskeller;
Nicole Baur;
Jean Harrington;
(2019)
Standards, Harmonization and Cultural Differences: Examining the Implementation of a European Stem Cell Clinical Trial
(/isis/citation/CBB953736485/)
Article
Shi Lin Loh;
Sulfikar Amir;
(June 2019)
Healing Fukushima: Radiation hazards and disaster medicine in post-3.11 Japan
(/isis/citation/CBB754363980/)
Article
Nishizaka, Aug;
(June 2011)
The embodied organization of a real-time fetus: The visible and the invisible in prenatal ultrasound examinations
(/isis/citation/CBB383905731/)
Article
Chia-Ling Wu;
Jung-Ok Ha;
Azumi Tsuge;
(March 2020)
Data Reporting as Care Infrastructure: Assembling ART Registries in Japan, Taiwan, and South Korea
(/isis/citation/CBB772486717/)
Book
Tatsuya Moima;
(2012)
Risuku ka sareru shintai—Gendai igaku to touchi no tekunorojī リスク化される身体—現代医学と統治 のテクノロジ [Body as Risk—Modern Medicine and the Technology of Governance]
(/isis/citation/CBB420487829/)
Book
Srinivas, Smita;
(2012)
Market Menagerie: Health and Development in Late Industrial States
(/isis/citation/CBB001213400/)
Article
Donzé, Pierre-Yves;
(2010)
Making Medicine a Business in Japan: Shimadzu Co. and the Diffusion of Radiology (1900--1960)
(/isis/citation/CBB001220551/)
Article
Colleen Lanier-Christensen;
(September 2021)
Creating Regulatory Harmony: The Participatory Politics of OECD Chemical Testing Standards in the Making
(/isis/citation/CBB606231580/)
Article
Ignace Schoot;
Charles Mather;
(2022)
Opening Up Containment
(/isis/citation/CBB238068628/)
Article
Christy Spackman;
Gary A. Burlingame;
(June 2018)
Sensory politics: The tug-of-war between potability and palatability in municipal water production
(/isis/citation/CBB215070697/)
Article
Judy Z Segal;
(August 2018)
Sex, drugs, and rhetoric: The case of flibanserin for ‘female sexual dysfunction’
(/isis/citation/CBB311917478/)
Article
Vincent Ialenti;
(June 2021)
Drum breach: Operational temporalities, error politics and WIPP’s kitty litter nuclear waste accident
(/isis/citation/CBB071677242/)
Be the first to comment!